The pathobiology of the oligodendrocyte

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 2, 1997, Pages 111-124

  Ludwin, Samuel K ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEMYELINATION; HUMAN; MYELINATION; OLIGODENDROGLIA; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0030773792     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199702000-00001     Document Type: Review

References (113)

1. Ludwin SK. Remyelination in the central nervous system and the peripheral nervous system. Adv Neurol 1988;47:215-54
2. Ludwin SK. Pathology of the myelin sheath. In: Waxman SG, Kocsis JD, Stys PK, eds. The axon: Structure, function and pathophysiology. New York: Oxford University Press, 1995:412-37
3. Pfeiffer SE, Warrington AE, Bansal R. The oligodendrocyte and its many cellular processes. Trends Cell Biol 1993;3:191-97
4. McLaurin JA, Yong VW. Oligodendrocytes and myelin. Neurol Clin 1995;13:23-49
5. Barres BA, Raff MC. Control of oligodendrocyte number in the developing rat optic nerve. Neuron 1994;12:935-42
6. Bansal R, Stefansson K, Pfeiffer SE. Proligodendroblast antigen (POA), a developmental antigen expressed by A007/O4-positive oligodendrocyte progenitors prior to the appearance of sulfatide and galactocerebroside. J Neurochem 1992;58:2221-29
7. Goldman JE. Regulation of oligodendrocyte differentiation. Trends Neurosci 1992;15:359-62
8. Levison SW, Chuang C, Abramson BJ, Goldman JE. The migrational patterns and developmental fates of glial precursors in the rat subventricular zone are temporally regulated. Development 1993;119:611-22
9. Miller RH, ffrench-Constant C, Raff MC. The macroglial cells of the rat optic nerve. Annu Rev Neurosci 1989;12:517-34
10. Mckinnon RD, Smith C, Behar T, Smith T, Dubois-Dalcq M. Distinct effects of bFGF and PDGF on oligodendrocyte progenitor cells. Glia 1993;7:245-54
11. Gard AL, Burrell MR, Pfeiffer SE, Rudge JS, Williams WC. Astroglial control of oligodendrocyte survival mediated by PDGF and leukemia inhibitory factor-like protein. Development 1995;121:2187-97
12. McMorris FA, Mozell RL, Carson MJ, Shinar Y, Meyer RD, Marchetti N. Regulation of oligodendrocyte development and central nervous system myelination by insulin-like growth factors. Ann N Y Acad Sci 1993;692:321-34
13. Noll E, Miller RH. Regulation of oligodendrocyte differentiation: A role for retinoic acid in the spinal cord. Development 1994;120: 649-60
14. Skoff RP, Knapp PE. Division of astroblasts and oligodendroblasts in postnatal rodent brain - evidence for separate astrocyte and oligodendrocyte lineages. Glia 1991;4:165-74
15. Wood PM, Mora J. Source of remyelinating oligodendrocytes. Adv Neurol 1993;59:113-23
16. Vick RS, DeVries GH. Mitotic potential of adult rat oligodendrocytes in culture. J Neurosci Res 1992;33:68-74
17. Hart IK, Richardson WD, Raff MC. PDGF increases the expression of fos and jun in newly formed oligodendrocytes that have become resistant to the mitogenic effect of PDGF. Glia 1992;6: 310-13
18. McMorris FA, Mckinnon RD. Regulation of oligodendrocyte development and CNS myelination by growth factors: Prospects for therapy of demyelinating disease. Brain Pathol 1996;6:313-29
19. Moore GR, Kim SU, Chang E, Kim M. Myelin basic protein does not have a mitogenic effect on adult oligodendrocytes. Acta Neuropathologica 1995;89:431-37
20. Wood PM, Bunge RP. Evidence that axons are mitogenic for oligodendrocytes isolated from adult animals. Nature 1986;320:756-58
21. Barres BA, Raff MC. Proliferation of oligodendrocyte precursor cells depends on electrical activity in axons. Nature 1993;361: 258-60
22. Warrington AE, Barbarese E, Pfeiffer SE. Differential myelinogenic capacity of specific developmental stages of the oligodendrocyte lineage upon transplantation into hypomyelinating hosts. J Neurosci Res 1993;34:1-13
23. Hardy R, Reynolds R. Neuron-oligodendroglial interactions during central nervous system development. J Neurosci Res 1993;36: 121-26
24. Williams BP, Price J. What have tissue culture studies told us about the development of oligodendrocytes. Bioessays 1992;14: 693-98
25. Ono K, Bansal R, Payne J, Rutishauser U, Miller RH. Early development and dispersal of oligodendrocyte precursors in the embryonic chick spinal cord. Development 1995;121:1743-54
26. Williams BP. Precursor cell types in the germinal zone of the cerebral cortex. Bioessays 1995;17:391-93
27. Sawamura S, Sawada M, Ito M, et al. The bipotential glial progenitor cell line can develop into both oligodendrocytes and astrocytes in the mouse forebrain. Neurosci Lett 1995;188:1-4
28. Franklin RJ, Blakemore WF. Glial-cell transplantation and plasticity in the O-2A lineage-implications for CNS repair. [Review]. Trends Neurosci 1995;18:151-56
29. Trotter J, Crang AJ, Schachner M, Blakemore WF. Lines of glial precursor cells immortalised with a temperature-sensitive oncogene give rise to astrocytes and oligodendrocytes following transplantation into demyelinated lesions in the central nervous system. Glia 1993;9:25-40
30. Wolswijk G, Riddle PN, Noble M. Coexistence of perinatal and adult forms of a glial progenitor cell during development of the rat optic nerve. Development 1990;109:691-98
31. Scolding NJ, Rayner PJ, Sussman J, Shaw C, Compston DA. A proliferative adult human oligodendrocyte progenitor. Neuroreport 1995;6:441-45
32. Rivkin MJ, Flax J, Mozell R, Osathanondh R, Volpe JJ, Villa-Komaroff L. Oligodendroglial development in human fetal cerebrum. Ann Neurol 1995;38:92-101
33. Cuzner ML, Norton WT. Biochemistry of demyelination. Brain Pathol 1996;6:231-42
34. Duncan ID. Inherited disorders of myelination of the central nervous system. In: Kettenmann H, Ransom B, eds. Neuroglia. New York: Oxford University Press, 1995;990-1009
35. Campagnoni AT, Pribyl TM, Campagnoni CW, et al. Structure and developmental regulation of Golli-mbp, a 105-kilobase gene that encompasses the myelin basic protein gene and is expressed in cells in the oligodendrocyte lineage in the brain. J Biol Chem 1993;268:4930-38
36. Li C, Tropak MB, Gerlai R, et al. Myelination in the absence of myelin-associated glycoprotein. Nature 1994;369:747-50
37. Boison D, Bussow H, D'Urso D, Muller HW, Stoffel W. Adhesive properties of proteolipid protein are responsible for the compaction of CNS myelin sheaths. J Neurosci 1995;15:5502-13
38. Staugaitis SM, Colman DR, Pedraza L. Membrane adhesion and other functions for the myelin basic proteins. [Review]. Bioessays 1996;18:13-18
39. Yong VW, Dooley NP, Noble PG. Protein kinase C in cultured adult human oligodendrocytes: A potential role for isoform alpha as a mediator of process outgrowth. J Neurosci Res 1994;39:83-96
40. Ludwin SK. Evolving concepts and issues in remyelination. Dev Neurosci 1989;11:140-48
41. Kirischuk S, Neuhaus J, Verkhratsky A, Kettenmann H. Preferential localization of active mitochondria in process tips of immature retinal oligodendrocytes. Neuroreport 1995;6:737-41
42. Asou H, Hamada K, Miyazaki T, et al. CNS myelinogenesis in vitro: Time course and pattern of rat oligodendrocyte development. J Neurosci Res 1995;40:519-34
43. Ludwin SK, Szuchet S. Myelination by mature ovine oligodendrocytes in vivo and in vitro: Evidence that different steps in the myelination process are independently controlled. Glia 1993;8: 219-31
44. Oumesmar BN, Vignais L, Duhamel-Clerin E, Avellana-Adalid V, Rougon G, Baron-Van Evercooren A. Expression of the highly polysialylated neural cell adhesion molecule during postnatal myelination and following chemically induced demyelination of the adult mouse spinal cord. Eur J Neurosci 1995;7:480-91
45. Shaw CE, Milner R, Compston AS, ffrench-Constant C. Analysis of integrin expression on oligodendrocytes during axo-glial interaction by using rat-mouse xenocultures. J Neurosci 1996;16: 1163-72
46. ffrench-Constant C, Mathews GA. Brain repair: Lessons from developmental biology. J Neurol 1994;242:S29-S32
47. Duncan ID. Glial cell transplantation and remyelination of the central nervous system. Neuropathol Appl Neurobiol 1996;22:87-100
48. Baron-Van Evercooren A, Duhamelclerin E, Boutry JM, Hauw JJ, Gumpel M. Pathways of migration of transplanted Schwann cells in the demyelinated mouse spinal cord. J Neurosci Res 1993;35: 428-38
49. Tontsch U, Archer DR, Dubois-Dalcq M, Duncan ID. Transplantation of an oligodendrocyte cell line leading to extensive myelination. Proc Natl Acad Sci U S A 1994;91:11616-20
50. Groves AK, Barnett SC, Franklin RJM, et al. Repair of demyelinated lesions by transplantation of purified 0-2A progenitor cells. Nature 1993;362:453-55
51. Blakemore WF, Crang AJ, Franklin RJ, Tang K, Ryder S. Glial cell transplants that are subsequently rejected can be used to influence regeneration of glial cell environments in the CNS. Glia 1995;13:79-91
52. Rubin BP, Dusart I, Schwab ME. A monoclonal antibody (IN-1) which neutralizes neurite growth inhibitory proteins in the rat CNS recognizes antigens localized in CNS myelin. J Neurocytol 1994;23:209-17
53. Eitan S, Zisling R, Cohen A, et al. Identification of an interleukin 2-like substance as a factor cytotoxic to oligodendrocytes and associated with central nervous system regeneration. Proc Natl Acad Sci USA 1992;89:5442-46
54. Lang DM, Rubin BP, Schwab ME, Stuermer CA. CNS myelin and oligodendrocytes of the Xenopus spinal cord-but not optic nerve-are nonpermissive for axon growth. J Neurosci 1995;15:99-109
55. Colello RJ, Pott U, Schwab ME. The role of oligodendrocytes and myelin on axon maturation in the developing rat retinofugal pathway. J Neurosci 1994;14:2594-2605
56. Byravan S, Foster LM, Phan T, Verity AN, Campagnoni AT. Murine oligodendroglial cells express nerve growth factor. Proc Natl Acad Sci U S A 1994;91:8812-16
57. Brosnan CF, Raine CS. Mechanisms of immune injury in multiple sclerosis. Brain Pathol 1996;6:243-57
58. Scolding NJ, Zajicek JR, Wood N, Compston DA. The pathogenesis of demyelinating disease. Prog Neurobiol 1994;43:143-73
59. Compston DAS, Scolding N, Wren D, Noble M. The pathogenesis of demyelinating disease - insights from cell biology. Trends Neurosci 1991;14:175-82
60. Hartung HP, Jung SF, Stoll G, et al. Inflammatory mediators in demyelinating disorders of the CNS and PNS. J Neuroimmunol 1992;40:197-210
61. Friede RL, Bruck W. Macrophage functional properties during myelin degradation. In: Seil FJ, ed. Advances in neurology, Vol. 59. New York: Raven Press, Ltd., 1993:327-36
62. Selmaj K, Raine CS, Farooq M, Norton WT, Brosnan CF. Cytokine cytotoxicity against oligodendrocytes - apoptosis induced by lymphotoxin. J Immunol 1991;147:1522-29
63. Mclaurin J, D'Souza S, Stewart J, et al. Effect of tumor necrosis factor a and b on human oligodendrocytes and neurons in culture. Int J Devl Neuroscience 1995;13:369-81
64. Brett R, Rumsby MG. Evidence of free radical damage in the central nervous system of guinea-pigs at the prolonged acute and early relapse stages of chronic relapsing experimental allergic encephalomyelitis. Neurochem Int 1993;23:35-44
65. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 1993;151:2132-41
66. Mitrovic B, Ignarro LJ, Vinters HV, et al. Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes. Neurosci 1995;65:531-39
67. Zajicek J, Wing M, Skepper J, Compston A. Human oligodendrocytes are not sensitive to complement. A study of CD59 expression in the human central nervous system. Lab Invest 1995;73: 128-38
68. Smith KJ, Hall SM. Central demyelination induced in vivo by the calcium ionophore ionomycin. Brain 1994;117:1351-56
69. Scolding NJ, Morgan BP, Campbell AK, Compston DAS. The role of calcium in rat oligodendrocyte injury and repair. Neurosci Lett 1992;135:95-98
70. Allen IV. Pathology of multiple sclerosis. In: Matthews WB, ed. McAlpine's multiple sclerosis. Edinborough: Churchill Livingstone, 1991:341-78
71. Antel JP, Williams K, Blain M, McRea E, Mclaurin J. Oligodendrocyte lysis by CD4+ T cells independent of tumor necrosis factor. Ann Neurol 1994;35:341-48
72. Selmaj K, Brosnan CF, Raine CS. Colocalization of lymphocytes bearing gamma delta T-cell receptor and heat shock protein hsp65 oligodendrocytes in multiple sclerosis. Proc Natl Acad Sci USA 1991;88:6452-56
73. Brosnan CF, Battistini L, Gao YL, Raine CS, Aquino DA. Heat shock proteins and multiple sclerosis: A review. J Neuropathol Exp Neurol 1996;55:389-402
74. D'Souza SD, Antel JP, Freedman MS. Cytokine induction of heat shock protein expression in human oligodendrocytes: An interleukin-1-mediated mechanism. J Neuroimmunol 1994;50:17-24
75. van Noort JM, van Sechel AC, Bajramovic JJ, et al. The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis [see comments]. Nature 1995;375:798-801
76. Chuaqui R, Tapia J. Histologic assessment of the age of recent brain infarcts in man. J Neuropathol Exp Neurol 1993;52:481-89
77. Oka A, Belliveau MJ, Rosenberg PA, Volpe JJ. Vulnerability of oligodendroglia to glutamate - pharmacology, mechanisms, and prevention. J Neurosci 1993;13:1441-53
78. Yoshioka A, Hardy M, Younkin DP, Grinspan JB, Stern JL, Pleasure D. Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors mediate excitotoxicity in the oligodendroglial lineage. J Neurochem 1995;64:2442-48
79. Qi Y, Jamindar TM, Dawson G. Hypoxia alters iron homeostasis and induces ferritin synthesis in oligodendrocytes. J Neurochem 1995;64:2458-64
80. Cohen RI, Almazan G. Norepinephrine-stimulated PI hydrolysis in oligodendrocytes is mediated by alpha-1A-adrenoceptors. Neuroreport 1993;4:1115-18
81. Ozawa K, Suchanek G, Breitschopf H, et al. Patterns of oligodendroglia pathology in multiple sclerosis. Brain 1994;117:1311-22
82. Lucchinetti CF, Bruck W, Rodriguez M, Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol 1996;6:259-74
83. Yasuda T, Grinspan J, Stern J, Franceschini B, Bannerman P, Pleasure D. Apoptosis occurs in the oligodendroglial lineage, and is prevented by basic fibroblast growth factor. J Neurosci Res 1995;40:306-17
84. Barres BA, Hart IK, Coles HSR, et al. Cell death in the oligodendrocyte lineage. J Neurobiol 1992;23:1221-30
85. Louis JC, Magal E, Takayama S, Varon S. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science 1993;259:689-92
86. Mizuguchi M, Ikeda K, Asada M, Mizutani S, Kamoshita S. Expression of Bcl-2 protein in murine neural cells in culture. Brain Res 1994;649:197-202
87. Eizenberg O, Faber-Elman A, Gottlieb E, Oren M, Rotter V, Schwartz M. Direct involvement of p53 in programmed cell death of oligodendrocytes. Embo J 1995;14:1136-44
88. D'Souza SD, Alinauskas KA, Antel JP. Ciliary neurotrophic factor selectively protects human oligodendrocytes from tumor necrosis factor-mediated injury. J Neurosci Res 1996;43:289-98
89. Li GL, Brodin G, Farooque M, et al. Apoptosis and expression of Bcl-2 after compression trauma to rat spinal cord. J Neuropathol Exp Neurol 1996;55:280-89
90. Seto K, Abe M, Ohya O, et al. A rat model of HTLV-I infection: Development of chronic progressive myeloneuropathy in seropositive WKAH rats and related apoptosis. Acta Neuropathol (Berl) 1995;89:483-90
91. Lassmann H, Bancher C, Breitschopf H, et al. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathologica 1995;89:35-41
92. Rodriguez M, Scheithauer B. Ultrastructure of multiple sclerosis. Ultrastruct Pathol 1994;18:3-13
93. Blakemore WF, Franklin RJ, Crang AJ. Repair of demyelinated lesions by glial cell transplantation. [Review]. J Neurol 1994;242: S61-S63
94. Carroll WM, Jennings AR. Early recruitment of oligodendrocyte precursors in CNS demyelination. Brain 1994;117:563-78
95. Prineas JW, Barnard RO, Kwon EE, Sharer LR, Cho ES. Multiple sclerosis - remyelination of nascent lesions. Ann Neurol 1993;33: 137-51
96. Armstrong R, Friedrich VL, Holmes KV, Duboisdalcq M. In vitro analysis of the oligodendrocyte lineage in mice during demyelination and remyelination. J Cell Biol 1990;111:1183-95
97. Espinosa De Los Monteras A, Zhang MS, de Vellis J. O2A progenitor cells transplanted into the neonatal rat brain develop into oligodendrocytes but not astrocytes. Proc Natl Acad Sci USA 1993;90:50-54
98. Prayoonwiwat N, Rodriguez M. The potential for oligodendrocyte proliferation during demyelinating disease. J Neuropathol Exp Neurol 1993;52:55-63
99. Knapp PE, Skoff RP, Booth CS. Oligodendrocytes possess essential prerequisites for remyelination. Division, motility, and structural rearrangement. Adv Neurol 1993;59:105-112
100. Komoly S, Hudson LD, Webster HD, Bondy CA. Insulin-like growth factor 1 gene expression is induced in astrocytes during experimental demyelination. Proc Natl Acad Sci USA 1992;89: 1894-98
101. Yao DL, Liu X, Hudson LD, Webster HD. Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 1995;92:6190-94
102. Miller DJ, Asakura K, Rodriguez M. Central nervous system remyelination clinical application of basic neuroscience principles. Brain Pathol 1996;6:331-44
103. Raine CS, Hintzen R, Traugott U, Moore GR. Oligodendrocyte proliferation and enhanced CNS remyelination after therapeutic manipulation of chronic relapsing EAE. Ann N Y Acad Sci 1988;540:712-14
104. Rodriguez M, Miller DJ. Immune promotion of central nervous system remyelination. Prog Brain Res 1994;103:343-55
105. Gumpel M, Tourbah A, Baron-Van Evercooren A. Myelin repair in the mammalian CNS - spontaneous repair and transplantation of myelin-forming cells. M S-Med Sci 1991;7:782-89
106. Baron-Van Evercooren A. Future prospects in transplantation. Ann Neurol 1994;36 Suppl:S151-S156
107. Lachapelle F, Duhamel-Clerin E, Gansmuller A, Baron-Van Evercooren A, Villarroya H, Gumpel M. Transplanted transgenically marked oligodendrocytes survive, migrate and myelinate in the normal mouse brain as they do in the shiverer mouse brain. Eur J Neurosci 1994;6:814-24
108. Targett MP, Sussman J, Scolding N, O'Leary MT, Compston DAS, Blakemore WF. Failure to achieve remyelination of demyelinated rat axons following transplantation of glial cells obtained from the adult human brain. Neuropathol Appl Neurobiol 1996;22:199-206
109. Chin SS-M, Goldman JE. Glial inclusions in CNS degenerative diseases. J Neuropathol Exp Neurol 1996;55:499-508
110. Costa C, Duyckaerts C. Oligodendroglial and neuronal inclusions in multiple system atrophy. Curr Opin Neurol 1993;6:865-71
111. Yamada T, Calne DB, Akiyama H, McGeer EG, Mcgeer PL. Further observations on tau-positive glia in the brains with progressive supranuclear palsy. Acta Neuropathol 1993;85:308-15
112. Feany MB, Dickson DW. Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol 1995;146:1388-96
113. Nishimura M, Tomimoto H, Suenaga T, et al. Immunocytochemical characterization of glial fibrillary tangles in Alzheimer's disease brain. Am J Pathol 1995;146:1052-58